RPX Files S-1 with the SEC It’s amazing what you can learn, or infer, from a Securities and Exchange Commission S-1 registration statement, which RPX has
Is Big Blue Co-Opting Innovation? It was reported in early 2011 that an application has been published for an IBM patent that apparently attempts to
Kappos: Make Patents More Relevant United States Patent and Trademark Office Commissioner David Kappos said last week at a Columbia University Technology Ventures gathering that
“There are no Copyrights,” says Godard Few filmmakers have been more influential than Jean-Luc Godard. Godard directed such French New Wave classics as Breathless, Weekend and Band of
Vision is Focus for Brussels IP 2010 Leading figures in European intellectual property business, regulation and finance, as well as several prominent Americans, will be
Flash of Anus – The Social Network is currently the top grossing movie in the land. It’s the story of how Facebook, now with 500
Cost Effectiveness + Patent Quality Controlling costs and managing risk is paramount for patent stakeholders. They can be a challenge when the average cost of
An Invention or a Discovery? Human genes have been called unpatentable and anti-competitive. Everyone from the ACLU to patients who demand cheaper tests are weighing in on the debate.